Generics Makers Infringe Lilly's Strattera Patent: Judge
A federal judge has ruled that Teva Pharmaceuticals USA Inc. and several other generic-drug makers have induced infringement of an Eli Lilly & Co. patent for attention deficit hyperactivity disorder treatment...To view the full article, register now.
Already a subscriber? Click here to view full article